| Date | Title | Description |
| 09.09.2024 | Panalgo Partners with COTA to Enhance AI & RWD-Enabled Cancer Care | What You Should Know:
– Panalgo, a provider of healthcare data analytics solutions, has announced a partnership with COTA, an organization focused on providing real-world data (RWD) for cancer care.
– The strategic collaboration will enable... |
| 30.04.2024 | Caris Life Sciences and COTA, Inc. Announce Collaboration to Expand Collective Multi-Modal Data Offering | The combined power of Caris' DNA, RNA, and imaging data with COTA's curated clinical data strengthens the offering to drive next-gen therapeutic development and advance patient care
IRVING, Texas and NEW YORK, April 30, 2024 /PRNewswire/ --... |
| 17.04.2024 | COTA & Sanofi Partner to Leverage Real-World Data and AI to Accelerate Cancer Trials | What You Should Know:
– COTA, a leading real-world data (RWD) and analytics company in oncology, has announced a new collaboration with Sanofi.
– The strategic partnership aims to leverage RWD and artificial intelligence (AI) to accelerate ... |
| 04.04.2024 | Cornerstone AI Taps Viraj Narayanan as Co-CEO to Drive Industry-wide Adoption of Clean Data in Healthcare and Pharmaceuticals | Amid growing regulatory pressure and oversight, Cornerstone AI provides life sciences an AI-based solution to cleaning data enabling faster and more cost-efficient drug development and commercialization
SAN FRANCISCO, April 4, 2024 /PRNewsw... |
| 14.11.2022 | HLTH22 Day 1 News Summary: Google, Maven, Highmark, LG, Others | Venture Capital, Private Equity Funding
Maven Clinic Secures $90M to Advance End-to-End Family Care Platform
Strategic Partnerships
Highmark Health, Google Cloud, League Launches Digital Health Platform
Highmark Health, Google Cloud, and Le... |
| 14.11.2022 | COTA Partners with Google Cloud to Transform Cancer Care | COTA, Inc., an oncology real-world data and analytics company, announced a new partnership with Google Cloud to develop algorithms that will extract and make sense of unstructured data from electronic health records (EHRs). The companies wi... |
| 26.10.2022 | Cota Receives Financing from Deerfield Management and Prior Investors | Cota, a New York-based oncology real-world data and analytics company, receives an investment from Deerfield Management, and existing investors.
The amount of the deal was not disclosed.
The company intends to use the funds to further expan... |
| 25.10.2022 | COTA Secures New Financing to Accelerate Cancer Research and Treatment Innovation | What You Should Know:
COTA Expands Services and Approaches Milestone of 2 Million Cancer Lives
Building on this latest round of financing, COTA is also announcing the expansion of its data platform to cover nearly 2 million cancer patient l... |
| 30.11.2021 | COTA Collaborates with University of Chicago Medicine and UT Southwestern on Research To Be Presented at the American Society for Hematology's Annual Meeting & Exposition | NEW YORK, Nov. 30, 2021 /PRNewswire/ -- COTA, Inc., an oncology real-world data and analytics company, today announced four of their abstracts will be showcased at the American Society for Hematology's (ASH) Annual Meeting & Exposition ... |
| 22.10.2021 | Veta Health Apoints CEO, Walgreens Leadership Appointments, Walmart’s New VP, Other Executive Appointments | James Sutcliffe, CEO at Veta Health
Veta Health, a global provider of digital solutions for remote patient care and chronic condition monitoring appoints James Sutcliffe as Chief Executive Officer. Sutcliffe will guide the strategic directi... |
| 24.06.2021 | COTA And University Of Chicago Medicine Collaborate To Study Racial Disparities In Cancer Treatment | Initial research will use real-world data to focus on multiple myeloma, a cancer that disproportionately affects Black Americans
COTA, Inc., an oncology real-world data and analytics company, and University of Chicago Medicine announced a r... |
| 06.04.2021 | Using data for anti-racist medical research: An interview with COTA’s chief legal officer | Nadine Peters has gone from Partner at Hogan Lovells and Verrill Dana to Counsel at HHS and PCORI to chief legal officer at COTA Inc., an oncologist-founded data startup seeking to bring clarity to cancer care by leveraging real-world data.... |
| 15.01.2021 | Getting Cancer Care Back On Track With RWD | Mike Doyle joined COTA as president and chief executive officer in October 2018. |
| 10.12.2020 | What’s coming up at MedCity INVEST Precision Medicine Day 3? | The MedCity INVEST Precision Medicine healthcare conference on December 9-11 draws healthcare and life science executives and investors as we spotlight progress in the development of diagnostics, clinical trial innovation, AI in drug develo... |
| 18.11.2020 | COTA Secures $34M | COTA, Inc., a healthcare technology company that uses real-world data to bring clarity to cancer care, today announced new capital and the expansion of its data access by over 300%, which now well exceeds one million oncology patient record... |
| 18.11.2020 | COTA Secures $34M in Growth Capital and Triples Data Access to Better Serve Life Science Partners and Provider Institutions | |
| 18.11.2020 | COTA Lands $34M to Drive Innovation in Oncology Using Real-World Data | What You Should Know:
– COTA, Inc., a healthcare technology company that uses real-world data to bring clarity to cancer care, has secured $34M in funding.
– Access to over one million patient data records and additional funding support enh... |
| 10.11.2020 | Cota Health raises $10 million to aggregate and analyze oncology data | Cota Health, an oncology-focused data curation and big data analytics platform, today raised $10 million in the form of a convertible loan from Varian Medical Technology. Under the agreement, Varian will offer its customers access to Cota’s... |
| 10.11.2020 | Cota Health raises $10 million to aggregate and analyze oncology data | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Cota Health, an oncology-focused data curation an... |
| 04.11.2020 | FDA Extends RCA With COTA to Explore COVID’s Effect on Cancer | What You Should Know:
– The FDA just extended its research collaboration agreement (RCA) with COTA, specifically looking at how COVID-19 is affecting cancer.
– With this expanded agreement, COTA and the FDA will use real-world data to explo... |
| 13.08.2020 | Mission Bio Lands $70M to Expand Cancer Therapies With Single-Cell Multi-Omics Platform | What You Should Know:
– Mission Bio raises $70 million in Series C funding led by Novo Growth to accelerate the development of cancer therapies with single-cell multi-omics.
– Mission Bio’s Tapestri Platform, the first single-cell platform ... |
| 30.04.2019 | Utilizing real-world evidence to improve oncology care | Clinical trials are time-consuming, expensive, and do not represent the broad patient population that will eventually receive these treatments. This isn’t anything new. It is a challenge the healthcare industry has faced for decades, even w... |
| 06.03.2018 | HIMSS18 Day 2 Coverage Highlights & Summary | Google Unveils New Cloud Healthcare API to Address Healthcare Data Interoperability
Google unveils their new Cloud Healthcare API, which addresses the significant interoperability challenges in healthcare data. The new API will provide a ro... |
| 01.03.2018 | Cota wraps up $40M Series C round to boost CNA system | “We see [IQVIA] as a tremendous new partner, in that they not only helped us feel out the funding needs of the company but strategically they’re a leader in healthcare information as well as in the CRO world,” Cota CFO Tom Gallucci said in ... |
| 22.02.2018 | Term Sheet — Thursday, February 22 | THE KING OF RIDE-HAILING
Good morning, Term Sheet readers.
Paid Content Securing the enterprise without boundaries From ExtraHop
Recently, reports emerged that Uber has decided to sell its Southeast Asia business to ride-hailing startup, Gr... |
| 22.02.2018 | Cota Lands $40M to Accelerate Value-based Precision Medicine | Cota, a NYC-based healthcare data and analytics company bridging precision medicine to population health has raised $40 million in Series C funding led by QVIA and was contributed to by EW Healthcare Partners. Memorial Sloan Kettering Cance... |
| 21.02.2018 | Cota Raises $40M Series C | Cota Inc., a healthcare real-world evidence and data analytics company bridging precision medicine to population health, today announced the completion of a Series C round of financing led by IQVIA (NYSE: IQV) with major participation by EW... |
| 21.02.2018 | Cota Raises $40M Series C | Cota Inc., a healthcare real-world evidence and data analytics company bridging precision medicine to population health, today announced the completion of a Series C round of financing led by IQVIA (NYSE: IQV) with major participation by EW... |
| 21.02.2018 | Cota Raises $40M in Series C Financing | Cota, Inc., a NYC-based healthcare real-world evidence and data analytics company, completed a $40M Series C round of financing.
The round was led by IQVIA (NYSE: IQV) with participation from EW Healthcare Partners, Memorial Sloan Kettering... |
| 21.02.2018 | Cota Announces $40 Million Series C Financing to Advance Classification System | Feb 21 2018
NEW YORK, NY—Cota Inc., a healthcare real-world evidence and data analytics company bridging precision medicine to population health, today announced the completion of a Series C round of financing led by IQVIA (NYSE:IQV) with ... |
| 10.11.2017 | Memorial Sloan Kettering and Cota want to use data to advance cancer treatment | The cancer center can then use the resulting datasets to improve patient care and accelerate research efforts.
In a phone interview, Stuart Goldberg, Cota’s chief scientific officer, said talks between the organizations began about a year a... |
| 11.06.2017 | Can Flatiron Health redeem EHRs? | That’s the aim behind Flatiron Health’s OncoEMR.
The New York City-based company was founded in 2012 by Nat Turner and Zach Weinberg, two young entrepreneurs who sold their ad-tech company, Invite Media, to Google in 2010. And the duo has b... |
| - | Cota wraps up $40M Series C round to boost CNA system | New York City-based Cota, an oncology-focused startup that relies on real-world evidence to deliver precision medicine, has completed a $40 million Series C financing round led by IQVIA.
Other participants included EW Healthcare Partners, M... |
| - | Can Flatiron Health redeem EHRs? | EHRs have come to represent necessary evils in healthcare. Millions have been invested in EHR implementations and in some instances, they have become technologies that providers love to hate.
One company, however, is attempting to redefine ... |
| - | What’s coming up at MedCity INVEST Precision Medicine Day 3? | The MedCity INVEST Precision Medicine healthcare conference on December 9-11 draws healthcare and life science executives and investors as we spotlight progress in the development of diagnostics, clinical trial innovation, AI in drug develo... |
| - | COTA and GTC Partner to Improve Precision Oncology | What You Should Know:
– COTA, Inc., an oncology real-world data and analytics company, today announced a new partnership with Genomic Testing Cooperative (GTC), a molecular testing company.
– GTC has a very innovative approach to genetic te... |
| - | Utilizing real-world evidence to improve oncology care | Oncology care is at a turning point, both in how care is delivered and in the number of treatments available to patients. There has been a wave of innovation in immuno-oncology, personalized medicine, and unprecedented strategic guidance fr... |
| - | Using data for anti-racist medical research: An interview with COTA’s chief legal officer | Nadine Peters has gone from Partner at Hogan Lovells and Verrill Dana to Counsel at HHS and PCORI to chief legal officer at COTA Inc., an oncologist-founded data startup seeking to bring clarity to cancer care by leveraging real-world data.... |
| - | Memorial Sloan Kettering and Cota want to use data to advance cancer treatment | Two New York City-based organizations — Memorial Sloan Kettering Cancer Center and Cota — have partnered on an initiative aimed at precision oncology research and treatment.
MSK will give Cota anonymized clinical data. The startup will run ... |
